Skip to contentO
Organon & Co.
O
OGNOrganon & Co. Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.60B$1.60Bderived+7.6% vs Q4 2022 Net Income$546.00M$546.00Mderived+405.6% vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Organon & Co. · CIK 1821825 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Cash Flowderived$397,000,000+48.7% Free Cash Flowderived$318,000,000+55.9% Margins · derivedNet margin34.2%+26.9 pt vs Q4 2022
ended Dec 31, 2023 · filed Feb 26, 2024 · 57 d after period end